529 related articles for article (PubMed ID: 29207054)
1. Use of methylation profiling to identify significant differentially methylated genes in bone marrow mesenchymal stromal cells from acute myeloid leukemia.
Huang J; Liu Z; Sun Y; Zhong Q; Xu L; Ou R; Li C; Chen R; Yao M; Zhang Q; Liu S
Int J Mol Med; 2018 Feb; 41(2):679-686. PubMed ID: 29207054
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
3. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
4. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
Wang Y; Zhao Q; Lan N; Wang S
Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
[TBL] [Abstract][Full Text] [Related]
5. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
6. Region-Specific Methylation Profiling in Acute Myeloid Leukemia.
Cecotka A; Polanska J
Interdiscip Sci; 2018 Mar; 10(1):33-42. PubMed ID: 29405013
[TBL] [Abstract][Full Text] [Related]
7. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
9. Abnormal DNA methylation may contribute to the progression of osteosarcoma.
Chen XG; Ma L; Xu JX
Mol Med Rep; 2018 Jan; 17(1):193-199. PubMed ID: 29115427
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
11. [Studies on gene expression and the 5' CpG islands methylation status of E-cadherin in acute myeloid leukemia].
Gao F; Li Y; Liu W; Lu XL; Li X; Wang PP; Liu YP
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):25-7. PubMed ID: 16732935
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.
Zhao X; Tian X; Kajigaya S; Cantilena CR; Strickland S; Savani BN; Mohan S; Feng X; Keyvanfar K; Dunavin N; Townsley DM; Dumitriu B; Battiwalla M; Rezvani K; Young NS; Barrett AJ; Ito S
Br J Haematol; 2016 Nov; 175(3):427-439. PubMed ID: 27433923
[TBL] [Abstract][Full Text] [Related]
13. CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.
Spencer DH; Russler-Germain DA; Ketkar S; Helton NM; Lamprecht TL; Fulton RS; Fronick CC; O'Laughlin M; Heath SE; Shinawi M; Westervelt P; Payton JE; Wartman LD; Welch JS; Wilson RK; Walter MJ; Link DC; DiPersio JF; Ley TJ
Cell; 2017 Feb; 168(5):801-816.e13. PubMed ID: 28215704
[TBL] [Abstract][Full Text] [Related]
14. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
15. Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
Barrera-Ramirez J; Lavoie JR; Maganti HB; Stanford WL; Ito C; Sabloff M; Brand M; Rosu-Myles M; Le Y; Allan DS
Stem Cell Rev Rep; 2017 Dec; 13(6):817-825. PubMed ID: 28918518
[TBL] [Abstract][Full Text] [Related]
16. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
17. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
[TBL] [Abstract][Full Text] [Related]
18. Selective variegated methylation of the p15 CpG island in acute myeloid leukemia.
Dodge JE; List AF; Futscher BW
Int J Cancer; 1998 Nov; 78(5):561-7. PubMed ID: 9808523
[TBL] [Abstract][Full Text] [Related]
19. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML).
Yan-Fang T; Jian N; Jun L; Na W; Pei-Fang X; Wen-Li Z; Dong W; Li P; Jian W; Xing F; Jian P
BMC Med Genet; 2013 Jul; 14():74. PubMed ID: 23870168
[TBL] [Abstract][Full Text] [Related]
20. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.
Kroeger H; Jelinek J; Estécio MR; He R; Kondo K; Chung W; Zhang L; Shen L; Kantarjian HM; Bueso-Ramos CE; Issa JP
Blood; 2008 Aug; 112(4):1366-73. PubMed ID: 18523155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]